Physician

Rachel Jane Chase, MD

According to 2025 Medicare claims, Rachel Chase, MD (NPI: 1518052893) practices rheumatology in the Louisville/Jefferson County, KY-IN market, with the plurality of this provider's patient population coming from Jefferson, KY. This provider's primary affiliated billing organization is KENTUCKIANA CENTER FOR BETTER BONE & JOINT HEALTH PLLC (NPI: 1922081546; TIN: 611357515) and primary practice location at 40202-1439. Chase is affiliated with the MountainStar Care Partners ACO (ACO ID: A5181), participating under the MSSP model.

Chase's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 862 traditional Medicare patients, billed 519,027 HCPCS/CPT codes, and received $5,702,495 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 2,793 prescription claims across 709 beneficiaries totaling $1,437,846 in drug costs, led by Humira(Cf) Pen (Adalimumab). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $2,375,764 to $5,702,495. Similarly, Part D prescription costs have risen steadily, from $1,029,574 to $1,437,846. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	631	99,184	$2,375,764
2016	658	123,514	$2,643,693
2017	705	147,273	$3,093,335
2018	725	143,195	$3,270,216
2019	742	147,207	$3,126,657
2020	738	219,314	$4,725,233
2021	739	202,040	$3,593,643
2022	850	265,119	$3,716,513
2023	891	424,726	$6,179,824
2024	862	519,027	$5,702,495

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	563	3,694	$1,029,574
2016	490	3,650	$763,090
2017	542	3,796	$886,666
2018	525	3,706	$965,903
2019	493	3,253	$1,043,098
2020	470	3,079	$975,781
2021	513	2,810	$1,255,747
2022	616	2,691	$1,604,425
2023	602	2,232	$987,055
2024	709	2,793	$1,437,846

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	382	858	$119
96413	Administration of chemotherapy into vein, 1 hour or less	281	1,783	$89
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	237	308	$81
96401	Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle	156	1,422	$50
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	590	1,155	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	44	1,316	$320,657
Enbrel Sureclick	Etanercept	28	784	$210,091
Orencia Clickject	Abatacept	32	980	$206,923
Rinvoq	Upadacitinib	21	810	$180,018
Cimzia (2 Pack)	Certolizumab Pegol	11	448	$90,077

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Rachel Jane Chase, MD?

Tedicare shows public-source Medicare data for Rachel Jane Chase, MD (NPI 1518052893), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rachel Jane Chase, MD have ACO affiliation data?

Rachel Jane Chase, MD is shown with ACO affiliation data for MountainStar Care Partners ACO (MSSP, ACO ID A5181).

What billing organization is linked to Rachel Jane Chase, MD?

Rachel Jane Chase, MD is linked to KENTUCKIANA CENTER FOR BETTER BONE & JOINT HEALTH PLLC (billing NPI 1922081546) in the available physician profile data.

Does Rachel Jane Chase, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.